{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:05:32Z","timestamp":1791317132810,"version":"4.3.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T00:00:00Z","timestamp":1477267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11899-016-0355-9","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T03:31:41Z","timestamp":1477279901000},"page":"514-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":177,"title":["Extranodal NK\/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases"],"prefix":"10.1007","volume":"11","author":[{"given":"Bradley M.","family":"Haverkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenggang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon G.","family":"Freud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu-Welliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"355_CR1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.seminhematol.2013.11.007","volume":"51","author":"R Suzuki","year":"2014","unstructured":"Suzuki R. Pathogenesis and treatment of extranodal natural killer\/T-cell lymphoma. Semin Hematol. 2014;51:42\u201351.","journal-title":"Semin Hematol"},{"key":"355_CR2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/annonc\/mdp418","volume":"21","author":"R Suzuki","year":"2010","unstructured":"Suzuki R et al. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. 2010;21:1032\u201340.","journal-title":"Ann Oncol"},{"key":"355_CR3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol. 2006;24:612\u20138.","journal-title":"J Clin Oncol"},{"key":"355_CR4","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113:3931\u20137.","journal-title":"Blood"},{"key":"355_CR5","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124\u201330.","journal-title":"J Clin Oncol"},{"key":"355_CR6","first-page":"23","volume":"26","author":"BM William","year":"2013","unstructured":"William BM, Armitage JO. International analysis of the frequency and outcomes of NK\/T-cell lymphomas. Best practice & research. Clinical Haematol. 2013;26:23\u201332. Review with additional background on NHL Classification Project (ILSG) PTCLP, and T-cell Lymphoma Project.","journal-title":"Clinical Haematol"},{"key":"355_CR7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164:536\u201345. SEER data showing increasing incidence of ENKTL-NT in the U.S.","journal-title":"Br J Haematol"},{"key":"355_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","volume":"138","author":"J Sun","year":"2012","unstructured":"Sun J et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol. 2012;138:429\u201334.","journal-title":"Am J Clin Pathol"},{"key":"355_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood. 2006;107:265\u201376.","journal-title":"Blood"},{"key":"355_CR10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/10428190802455867","volume":"49","author":"AN Abouyabis","year":"2008","unstructured":"Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008;49:2099\u2013107.","journal-title":"Leuk Lymphoma"},{"key":"355_CR11","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1182\/blood-2010-11-319913","volume":"117","author":"P Porcu","year":"2011","unstructured":"Porcu P, Caligiuri M. A sheep in wolf\u2019s clothing. Blood. 2011;117:1438\u20139.","journal-title":"Blood"},{"key":"355_CR12","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","volume":"38","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH et al. Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol. 2014;38:e60\u201371. Reviews questions related to the importance of precise cell lineage (\u03b1\u03b2-type T cell, \u03b3\u03b4 T cell, or NK cell), the implications of Epstein-Barr virus infection, the significance of anatomic location including nodal disease, and the question of further categorization of enteropathy-associated T-cell lymphomas.","journal-title":"Am J Surg Pathol"},{"key":"355_CR13","unstructured":"Swerdlow, S.H., Campo, E., Harris, N.L. & al., e. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues (ed 4th). (Lyon France: IARC, 2008)."},{"key":"355_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","volume":"36","author":"T Pongpruttipan","year":"2012","unstructured":"Pongpruttipan T et al. Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta\/gammadelta T-cell origin: a comprehensive clinicopathologic and phenotypic study. Am J Surg Pathol. 2012;36:481\u201399.","journal-title":"Am J Surg Pathol"},{"key":"355_CR15","doi-asserted-by":"crossref","unstructured":"Jung KS, Cho SH, Kim SJ, Ko YH & Kim WS. Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma. Int J Hematol. 2016. Reports clinical presentation and outcomes of 5 patients with EBV-positive nodal T-cell lymphoma (PTCL-NOS), mainly showing overall aggressive clinical features and poor treatment outcomes.","DOI":"10.1007\/s12185-016-2068-1"},{"key":"355_CR16","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1007\/s13277-015-3485-0","volume":"36","author":"L Wang","year":"2015","unstructured":"Wang L et al. CD56-negative extranodal NK\/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Tumour Biol. 2015;36:7717\u201323. Reports clinical presentation and outcomes of 60 CD56- ENKTL-NT, mainly showing significant inferior overall survival compared to 228 CD56+ ENKTL-NT patients.","journal-title":"Tumour Biol"},{"key":"355_CR17","doi-asserted-by":"crossref","unstructured":"Haverkos BM, Huang Y, Gru A, Baiocchi RA & Porcu P. Elevated plasma Epstein-Barr virus DNA at diagnosis predicts a poor prognosis in peripheral T-cell lymphomas. Clin Lymphoma Myeloma Leuk 2015. Reported elevated cell-free EBV-DNA in 25% (N\u2009=\u200915\/61) of PTCL patients at diagnosis. Elevated cell-free EBV-DNA was highly specific for EBER+ tumors and associated with worse survival compared to patients without elevated cell-free EBV-DNA.","DOI":"10.1016\/j.clml.2015.07.135"},{"key":"355_CR18","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390. Revised 2016 WHO classification of lymphoid neoplasms including updates on T\/NK-cell lymphoproliferative disorders.","journal-title":"Blood"},{"key":"355_CR19","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor A et al. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117:1447\u201352.","journal-title":"Blood"},{"key":"355_CR20","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89:3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"355_CR21","unstructured":"Federico M, et al. PTCL Registry Update. 2016;53. Upated enrollment on the T-cell Project presented at the T-cell Forum, January 2016."},{"key":"355_CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-015-2513-x","volume":"95","author":"SJ Wu","year":"2016","unstructured":"Wu SJ, Chiang CJ, Lin CT, Tien HF, Lai MS. A nationwide population-based cross-sectional comparison of hematological malignancies incidences between Taiwan and the United States of America. Annals of hematology. 2016;95:165\u20137. Cross sectional study showing higher incidence of T\/NK-cell neoplasms in Taiwan compared to the U.S.","journal-title":"Annals of hematology"},{"key":"355_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canep.2016.02.007","volume":"42","author":"BA Bassig","year":"2016","unstructured":"Bassig BA et al. Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001\u20132010. Cancer Epidemiol. 2016;42:15\u201323. Cross sectional study showing higher incidece of T\/NK-cell neoplasms in Hong Kong compared ot the U.S. Also, showed significantly lower incidence in both U.S. whites and U.S. Asians compared to Hong Kong.","journal-title":"Cancer Epidemiol"},{"key":"355_CR24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","volume":"90","author":"M Al-Hamadani","year":"2015","unstructured":"Al-Hamadani M et al. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol. 2015;90:790\u20135. Using the U.S. NCDB, Hispanics had higher rates of ENKTL-NT compared to non-Hispanics, and Native Americans had similar proportions of ENKTL-NT to Asians.","journal-title":"Am J Hematol"},{"key":"355_CR25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ejca.2015.07.009","volume":"51","author":"JM Michot","year":"2015","unstructured":"Michot JM et al. Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)\/T-cell lymphoma, nasal type. Eur J Cancer (Oxford, England: 1990). 2015;51:2386\u201395. French clinical trial in limited stage ENKTL-NT with 2 year OS of 72% using CCRT with ESHAP.","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"355_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/annonc\/mdn542","volume":"20","author":"A Jaccard","year":"2009","unstructured":"Jaccard A et al. L-asparaginase-based treatment of 15 western patients with extranodal NK\/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol. 2009;20:110\u20136.","journal-title":"Ann Oncol"},{"key":"355_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.anorl.2014.07.005","volume":"132","author":"A Picard","year":"2015","unstructured":"Picard A et al. Extranodal lymphoma of the head and neck: a 67-case series. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:71\u20135.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"355_CR28","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/annonc\/mdl015","volume":"17","author":"L Pagano","year":"2006","unstructured":"Pagano L et al. NK\/T-cell lymphomas \u2018nasal type\u2019: an Italian multicentric retrospective survey. Ann Oncol. 2006;17:794\u2013800. Reports clinical characteristics and outcomes of 26 cases of Caucasian ENKTL-NT from Italy.","journal-title":"Ann Oncol"},{"key":"355_CR29","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","volume":"117","author":"A Jaccard","year":"2011","unstructured":"Jaccard A et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study. Blood. 2011;117:1834\u20139.","journal-title":"Blood"},{"key":"355_CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2009.08010.x","volume":"148","author":"A Smith","year":"2010","unstructured":"Smith A et al. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol. 2010;148:739\u201353.","journal-title":"Br J Haematol"},{"key":"355_CR31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol. 2016;34:963\u201371. Using U.S. SEER data, reported higher rates of ENKTL-NT among Native Americans, APIs, and Hispanics compared to non-Hispanic whites. Survival varied significantly by race and ethnicity with blacks experiencing shorter survival.","journal-title":"J Clin Oncol"},{"key":"355_CR32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2141.2011.08982.x","volume":"156","author":"WZ Ai","year":"2012","unstructured":"Ai WZ et al. Racial patterns of extranodal natural killer\/T-cell lymphoma, nasal type, in California: a population-based study. Br J Haematol. 2012;156:626\u201332.","journal-title":"Br J Haematol"},{"key":"355_CR33","doi-asserted-by":"crossref","unstructured":"Karkera AC, Parsons BM, Borgert A & Go RS. NK\/T cell lymphoma in the U.S: A population-based study using the National Cancer Database from 1998\u20132012. J Clin Oncol. 2016;34. Provides most recent NCDB update with incidence of ENKTL-NT at 0.2% of NHL and 0.5% of T\/NK cell lymphomas.","DOI":"10.1200\/JCO.2016.34.15_suppl.e19038"},{"key":"355_CR34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/10428194.2014.909039","volume":"56","author":"L Khan","year":"2015","unstructured":"Khan L et al. A single institution experience of extranodal natural killer\/T cell lymphoma of nasal type. Leuk Lymphoma. 2015;56:80\u20134. Reports clinical characteristics and outcomes of 34 Canadian ENKTL-NT patients.","journal-title":"Leuk Lymphoma"},{"key":"355_CR35","first-page":"5088","volume":"120","author":"MX Welliver","year":"2012","unstructured":"Welliver MX et al. Utilization of EBV DNA copy number monitoring in extranodal NK lymphoma, nasal type in non Asian patients. ASH Ann Meet Abstr. 2012;120:5088.","journal-title":"ASH Ann Meet Abstr"},{"key":"355_CR36","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113:3931\u20137.","journal-title":"Blood"},{"key":"355_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12105-016-0698-5","volume":"10","author":"FH Kreisel","year":"2016","unstructured":"Kreisel FH. Hematolymphoid lesions of the sinonasal tract. Head Neck Pathol. 2016;10:109\u201317.","journal-title":"Head Neck Pathol"},{"key":"355_CR38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.amjoto.2014.07.012","volume":"36","author":"SM Kidwai","year":"2015","unstructured":"Kidwai SM, Parasher AK, Lin FY. An unusual presentation of NK\/T-cell lymphoma, nasal-type in the United States. Am J Otolaryngol. 2015;36:80\u20133.","journal-title":"Am J Otolaryngol"},{"key":"355_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","volume":"37","author":"S Li","year":"2013","unstructured":"Li S et al. Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol. 2013;37:14\u201323. Reports clinical characteristics and outcomes of 73 ENKTL-NT patients treated at MDACC.","journal-title":"Am J Surg Pathol"},{"key":"355_CR40","unstructured":"Qi S et al. Encouraging experience in the treatment of nasal type extra-nodal NK\/T-cell lymphoma in a non-Asian population. Leukemia & lymphoma, 1\u20139 (2016). Reports clinical characteristics and outcomes of 43 ENKTL-NT patients treated at MSKCC."},{"key":"355_CR41","first-page":"e408","volume":"7","author":"A Rahal","year":"2015","unstructured":"Rahal A, Reddy PS, Alvares C. Extranodal NK\/T-cell lymphoma, nasal type, presenting as a breast mass. Cureus. 2015;7:e408.","journal-title":"Cureus"},{"key":"355_CR42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.annder.2014.11.007","volume":"142","author":"E Freling","year":"2015","unstructured":"Freling E et al. Extranodal NK\/T-cell lymphoma, nasal-type, revealed by cutaneous breast involvement. Ann Dermatol Venereol. 2015;142:104\u201311.","journal-title":"Ann Dermatol Venereol"},{"key":"355_CR43","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1200\/JCO.2012.47.6796","volume":"32","author":"HJ Prajapati","year":"2014","unstructured":"Prajapati HJ et al. Primary CNS natural killer\/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature. J Clin Oncol. 2014;32:e26\u201329.","journal-title":"J Clin Oncol"},{"key":"355_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood-2014-12-616961","volume":"126","author":"F Ellin","year":"2015","unstructured":"Ellin F, Landstrom J, Jerkeman M, Relander T. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study. Blood. 2015;126:36\u201341. Swedish registry study reporting no risk of CNS disease in 0 of 26 ENKTL-NT patients.","journal-title":"Blood"},{"key":"355_CR45","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/annonc\/mdp412","volume":"21","author":"SJ Kim","year":"2010","unstructured":"Kim SJ et al. When do we need central nervous system prophylaxis in patients with extranodal NK\/T-cell lymphoma, nasal type? Ann Oncol. 2010;21:1058\u201363.","journal-title":"Ann Oncol"},{"key":"355_CR46","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","volume":"89","author":"JK Chan","year":"1997","unstructured":"Chan JK et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501\u201313.","journal-title":"Blood"},{"key":"355_CR47","doi-asserted-by":"crossref","unstructured":"Omori M, et al. Extranodal NK\/T-cell lymphoma, nasal type of the uterine cervix: a case report. Diagn Cytopathol. 2016.","DOI":"10.1002\/dc.23439"},{"key":"355_CR48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/1759-7714.12254","volume":"7","author":"CC Chien","year":"2016","unstructured":"Chien CC, Lee HS, Lin MH, Hsieh PP. Primary extranodal natural killer\/T-cell lymphoma of bronchus and lung: A case report and review of literature. Thoracic Cancer. 2016;7:140\u20134.","journal-title":"Thoracic Cancer"},{"key":"355_CR49","doi-asserted-by":"crossref","unstructured":"Shimatani Y, et al. Extranodal NK\/T-cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion. Neuropathology. 2016","DOI":"10.1111\/neup.12285"},{"key":"355_CR50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3960\/jslrt.55.157","volume":"55","author":"T Matsuo","year":"2015","unstructured":"Matsuo T, Tanaka T, Ichimura K, Meguri Y. Intraocular relapse with hypopyon and retinal infiltrates after chemotherapy and peripheral blood stem cell transplantation for extranodal NK\/T-cell lymphoma. J Clin Exp Hematopathol. 2015;55:157\u201361.","journal-title":"J Clin Exp Hematopathol"},{"key":"355_CR51","doi-asserted-by":"crossref","first-page":"618","DOI":"10.5021\/ad.2015.27.5.618","volume":"27","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Kim SH, Oh SH. CD56-negative extranodal NK\/T-cell lymphoma, nasal type, with extranasal cutaneous involvement. Ann Dermatol. 2015;27:618\u201320.","journal-title":"Ann Dermatol"},{"key":"355_CR52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pin.12346","volume":"65","author":"S Tajima","year":"2015","unstructured":"Tajima S, Takanashi Y, Koda K, Fukayama M. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK\/T-cell lymphoma arising in the lungs. Pathol Int. 2015;65:661\u20135.","journal-title":"Pathol Int"},{"key":"355_CR53","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1097\/MD.0000000000001151","volume":"94","author":"ZY Ye","year":"2015","unstructured":"Ye ZY et al. Primary esophageal extranasal NK\/T cell lymphoma with biphasic morphology: a case report and literature review. Medicine. 2015;94:e1151.","journal-title":"Medicine"},{"key":"355_CR54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jclinpath-2015-203188","volume":"68","author":"YH Huang","year":"2015","unstructured":"Huang YH, Huang CT, Tan SY, Chuang SS. Primary gastric extranodal natural killer\/T-cell lymphoma, nasal type, with acquisition of CD20 expression in the subcutaneous relapse: report of a case with literature review. J Clin Pathol. 2015;68:943\u20135.","journal-title":"J Clin Pathol"},{"key":"355_CR55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13000-015-0336-7","volume":"10","author":"Y Bi","year":"2015","unstructured":"Bi Y et al. Intravascular NK-cell lymphoma: a case report and review of the literature. Diagn Pathol. 2015;10:84.","journal-title":"Diagn Pathol"},{"key":"355_CR56","first-page":"322","volume":"60","author":"Y Xia","year":"2015","unstructured":"Xia Y et al. Extranodal NK\/T-cell lymphoma mimicking erythema multiforme. Ind J Dermatol. 2015;60:322.","journal-title":"Ind J Dermatol"},{"key":"355_CR57","first-page":"e12597","volume":"12","author":"SH Kim","year":"2015","unstructured":"Kim SH, Seon HJ, Choi YD, Yun SJ. Clinico-radiologic findings in primary cutaneous extranodal natural killer\/t-cell lymphoma, nasal type mimicking cellulitis of the left arm. Iran J Radiol. 2015;12:e12597.","journal-title":"Iran J Radiol"},{"key":"355_CR58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3904\/kjim.2015.30.1.122","volume":"30","author":"YL Lim","year":"2015","unstructured":"Lim YL, Pack HS, Park JE, Oh JR, Kong JH. Extranodal natural killer\/T-cell lymphoma of the tenosynovium of the hand. Korean J Int Med. 2015;30:122\u20134.","journal-title":"Korean J Int Med"},{"key":"355_CR59","first-page":"6399","volume":"7","author":"X Li","year":"2014","unstructured":"Li X et al. NK\/T cell lymphoma involving mediastinum: report of a case and review of literature. Int J Clin Exp Pathol. 2014;7:6399\u2013402.","journal-title":"Int J Clin Exp Pathol"},{"key":"355_CR60","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2169\/internalmedicine.53.2764","volume":"53","author":"YS Baek","year":"2014","unstructured":"Baek YS et al. Cardiac involvement in CD56 negative primary pancreatic extranodal NK\/T-cell lymphoma, nasal type, presenting with ventricular tachycardia during the early stages of chemotherapy. Intern Med (Tokyo, Japan). 2014;53:2333\u20136.","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"355_CR61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4046\/trd.2014.76.4.184","volume":"76","author":"K Kim","year":"2014","unstructured":"Kim K et al. Single pleural relapse of a nasal-type extranodal natural killer\/t-cell lymphoma: a case report. Tuberc Respir Dis. 2014;76:184\u20137.","journal-title":"Tuberc Respir Dis"},{"key":"355_CR62","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10072-014-1783-8","volume":"35","author":"B Cai","year":"2014","unstructured":"Cai B, Hu JJ, Tang QX, Lin W, Wang N. Primary meningeal NK\/T cell lymphoma masquerading as tuberculous meningitis. Neurol Sci. 2014;35:1467\u20139.","journal-title":"Neurol Sci"},{"key":"355_CR63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1746-1596-8-94","volume":"8","author":"Q Jiang","year":"2013","unstructured":"Jiang Q et al. An extraordinary T\/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature. Diagn Pathol. 2013;8:94.","journal-title":"Diagn Pathol"},{"key":"355_CR64","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","volume":"122","author":"L Quintanilla-Martinez","year":"2013","unstructured":"Quintanilla-Martinez L et al. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma. Blood. 2013;122:3101\u201310. Reports the clinicopathological features of 20 Mexican children with HVLL.","journal-title":"Blood"},{"key":"355_CR65","doi-asserted-by":"crossref","unstructured":"Lunning M, et al. Modified SMILE in the treatment of natural killer T-cell lymphoma, nasal and nasal type: a single center US experience. 2011.","DOI":"10.1182\/blood.V118.21.2688.2688"},{"key":"355_CR66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54\u201363.","journal-title":"J Clin Oncol"},{"key":"355_CR67","doi-asserted-by":"crossref","unstructured":"Yang Y, et al. Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study. Blood;126:1424\u20131432. quiz 1517 (2015). Large retrospective multi-center study showing that RT alone achieved a 5 year 88% OS in low risk limited stage ENKTL-NT","DOI":"10.1182\/blood-2015-04-639336"},{"key":"355_CR68","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","volume":"83","author":"B Wang","year":"2008","unstructured":"Wang B et al. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type. Am J Hematol. 2008;83:795\u20139.","journal-title":"Am J Hematol"},{"key":"355_CR69","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1042819031000067873","volume":"44","author":"Y Matsumoto","year":"2003","unstructured":"Matsumoto Y et al. Successful treatment with Erwinia L-asparaginase for recurrent natural killer\/T cell lymphoma. Leuk Lymphoma. 2003;44:879\u201382.","journal-title":"Leuk Lymphoma"},{"key":"355_CR70","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011;29:4410\u20136.","journal-title":"J Clin Oncol"},{"key":"355_CR71","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","volume":"27","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M et al. Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 2009;27:5594\u2013600.","journal-title":"J Clin Oncol"},{"key":"355_CR72","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","volume":"27","author":"SJ Kim","year":"2009","unstructured":"Kim SJ et al. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-cell lymphoma: Consortium for Improving Survival of Lymphoma study. J Clin Oncol. 2009;27:6027\u201332.","journal-title":"J Clin Oncol"},{"key":"355_CR73","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbmt.2015.05.003","volume":"21","author":"HY Yhim","year":"2015","unstructured":"Yhim HY et al. Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural killer\/T cell lymphoma. Biol Blood Marrow Transplant. 2015;21:1597\u2013604. Reports clinical characteristics and outcomes of 62 ENKTL-NT patients who underwent upfront autologous HCT.","journal-title":"Biol Blood Marrow Transplant"},{"key":"355_CR74","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12185-010-0726-2","volume":"92","author":"R Suzuki","year":"2010","unstructured":"Suzuki R. Treatment of advanced extranodal NK\/T cell lymphoma, nasal-type and aggressive NK-cell leukemia. Int J Hematol. 2010;92:697\u2013701.","journal-title":"Int J Hematol"},{"key":"355_CR75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","volume":"37","author":"HJ Kim","year":"2006","unstructured":"Kim HJ et al. High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplant. 2006;37:819\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"355_CR76","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdg458","volume":"14","author":"WY Au","year":"2003","unstructured":"Au WY et al. Autologous stem cell transplantation for nasal NK\/T-cell lymphoma: a progress report on its value. Ann Oncol. 2003;14:1673\u20136.","journal-title":"Ann Oncol"},{"key":"355_CR77","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.bbmt.2008.09.014","volume":"14","author":"J Lee","year":"2008","unstructured":"Lee J et al. Autologous hematopoietic stem cell transplantation in extranodal natural killer\/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant. 2008;14:1356\u201364.","journal-title":"Biol Blood Marrow Transplant"},{"key":"355_CR78","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3109\/10428194.2010.487958","volume":"51","author":"H Yokoyama","year":"2010","unstructured":"Yokoyama H et al. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer\/T cell lymphoma, nasal type. Leuk Lymphoma. 2010;51:1509\u201312.","journal-title":"Leuk Lymphoma"},{"key":"355_CR79","doi-asserted-by":"crossref","unstructured":"Tse E, et al. Allogeneic haematopoietic SCT for natural killer\/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group. Bone Marrow Transplant. 2014. Reports clinical characteristics and outcomes of 18 ENKTL-NT who underwent allogeneic HCT.","DOI":"10.1038\/bmt.2014.65"},{"key":"355_CR80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","volume":"37","author":"R Suzuki","year":"2006","unstructured":"Suzuki R et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant. 2006;37:425\u201331.","journal-title":"Bone Marrow Transplant"},{"key":"355_CR81","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/10428190500215191","volume":"46","author":"SM Bang","year":"2005","unstructured":"Bang SM et al. High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T\/NK-cell lymphoma. Leuk Lymphoma. 2005;46:1599\u2013604.","journal-title":"Leuk Lymphoma"},{"key":"355_CR82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1700606","volume":"19","author":"R Liang","year":"1997","unstructured":"Liang R et al. Autologous bone marrow transplantation for primary nasal T\/NK cell lymphoma. Bone Marrow Transplant. 1997;19:91\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"355_CR83","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.3109\/10428194.2015.1037764","volume":"56","author":"CP Fox","year":"2015","unstructured":"Fox CP et al. High-dose therapy and autologous stem cell transplantation for extra-nodal NK\/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Leuk Lymphoma. 2015;56:3295\u2013300. Largest analysis of ENKTL-NT patients from the West who underwent autologous HCT, reported by the EBMT (N\u2009=\u200928).","journal-title":"Leuk Lymphoma"},{"key":"355_CR84","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V126.23.3191.3191","volume":"126","author":"J Brammer","year":"2015","unstructured":"Brammer J et al. Multi-Center study of outcomes of hematopoietic stem cell transplantation (HSCT) in patients with extra-nodal natural killer\/T-cell lymphoma, nasal type (ENKL). Blood. 2015;126:3191. Multi-center retrospective study in 27 ENKTL-NT patients who received autologous and allogeneic HCT (14 autologous and 13 allogeneic) in the U.S.","journal-title":"Blood"},{"key":"355_CR85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hon.847","volume":"26","author":"R Suzuki","year":"2008","unstructured":"Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK\/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol. 2008;26:66\u201372.","journal-title":"Hematol Oncol"},{"key":"355_CR86","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","volume":"118","author":"R Suzuki","year":"2011","unstructured":"Suzuki R et al. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type. Blood. 2011;118:6018\u201322.","journal-title":"Blood"},{"key":"355_CR87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood. 2004;104:243\u20139.","journal-title":"Blood"},{"key":"355_CR88","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","volume":"18","author":"Y Ito","year":"2012","unstructured":"Ito Y et al. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res. 2012;18:4183\u201390.","journal-title":"Clin Cancer Res"},{"key":"355_CR89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmv.582","volume":"18","author":"H Kimura","year":"2008","unstructured":"Kimura H, Ito Y, Suzuki R, Nishiyama Y. Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol. 2008;18:305\u201319.","journal-title":"Rev Med Virol"},{"key":"355_CR90","first-page":"29","volume":"8","author":"KI Lei","year":"2002","unstructured":"Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer\/T-cell lymphoma. Clin Cancer Res. 2002;8:29\u201334.","journal-title":"Clin Cancer Res"},{"key":"355_CR91","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/jmv.23858","volume":"86","author":"DE Ouedraogo","year":"2014","unstructured":"Ouedraogo DE et al. Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant. J Med Virol. 2014;86:851\u20136.","journal-title":"J Med Virol"},{"key":"355_CR92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2009.07802.x","volume":"147","author":"R Liang","year":"2009","unstructured":"Liang R. Advances in the management and monitoring of extranodal NK\/T-cell lymphoma, nasal type. Br J Haematol. 2009;147:13\u201321.","journal-title":"Br J Haematol"},{"key":"355_CR93","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127:2007\u201317. Large study comparing clinical utility of quantifying cell free EBV-DNA compared to PBMCs. Plasma cell free EBV-DNA had higher specificity and sensitivity for EBV+ disease as compared with measuring EBV in PBMCs.","journal-title":"Blood"},{"key":"355_CR94","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"355_CR95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17:389\u2013400. Large retrospective multi-center study validating a new prognostic model in ENKTL-NT based on age, stage, lymph node involvement, non-nasal disease, and EBV-DNA viral load.","journal-title":"Lancet Oncol"},{"key":"355_CR96","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hed.23322","volume":"36","author":"H Hanakawa","year":"2014","unstructured":"Hanakawa H et al. Novel and simple prognostic index for nasal natural killer\/T-cell lymphoma. Head Neck. 2014;36:551\u20136.","journal-title":"Head Neck"},{"key":"355_CR97","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","volume":"12","author":"AD Zelenetz","year":"2014","unstructured":"Zelenetz AD et al. Non-Hodgkin\u2019s lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014;12:1282\u2013303.","journal-title":"J Natl Compr Canc Netw"},{"key":"355_CR98","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00277-015-2395-y","volume":"94","author":"XW Bi","year":"2015","unstructured":"Bi XW et al. Radiotherapy and PGEMOX\/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK\/T-cell lymphoma. Ann Hematol. 2015;94:1525\u201333. Clinical characteristics and outcomes of 63 newly diagnosed ENKTL-NT elderly patients treated with asparginase, gemcitabine, and oxaliplatin.","journal-title":"Ann Hematol"},{"key":"355_CR99","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/leu.2012.102","volume":"26","author":"C Liu","year":"2012","unstructured":"Liu C et al. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia. 2012;26:2303\u20139.","journal-title":"Leukemia"},{"key":"355_CR100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","volume":"32","author":"CM Bollard","year":"2014","unstructured":"Bollard CM et al. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol. 2014;32:798\u2013808. 21 patients treated with autologous CTLs directed at LMP1 and LMP2. 11 of 21 patients achieved complete responses without significant toxicity.","journal-title":"J Clin Oncol"},{"key":"355_CR101","first-page":"2028","volume":"63","author":"KC Chan","year":"2003","unstructured":"Chan KC et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 2003;63:2028\u201332.","journal-title":"Cancer Res"},{"key":"355_CR102","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00277-014-2015-2","volume":"93","author":"C Yoo","year":"2014","unstructured":"Yoo C et al. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer\/T cell lymphoma. Ann Hematol. 2014;93:995\u20131000.","journal-title":"Ann Hematol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-016-0355-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-016-0355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T22:05:47Z","timestamp":1657490747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-016-0355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":102,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1007\/s11899-016-0355-9","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}